Brief: Brii Biosciences Commits Additional Investment Of US$100 Mln For Investigational SARS-COV-2
07/09/2021 13:45
Sept 7 (Reuters) - Brii Biosciences Ltd 2137.HK :
* COMMITTING ADDITIONAL INVESTMENT OF US$100 MILLION, TO
ADVANCE
GLOBAL REGULATORY FILINGS FOR INVESTIGATIONAL SARS-COV-2
* ADDITIONAL INVESTMENT OF US$100 MILLION FOR CO'S
INVESTIGATIONAL
SARS-COV-2 COMBINATION THERAPY
Further company coverage: 2137.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brii Biosciences
See all newsBrief: BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
China's Brii Biosciences interim net loss narrows on lower R&D expenses
Brief: Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million
Brief: Brii Biosciences Says Arbitration Between Brii And Vir Remains In Early Stages With No Resolution
Brief: Brii Biosciences Submits Demand For Arbitration Against VIR